Stinging insect allergy and venom immunotherapy.

Area of Science:

• Entomology
• Allergology
• Immunology

Background:

• Hymenoptera insects (bees, wasps, ants) can cause severe allergic reactions, including anaphylaxis.
• Risk of future anaphylaxis varies based on prior sting reaction severity and allergy testing.
• Africanized bees present a unique aggressive threat in specific regions.

Purpose of the Study:

• To differentiate indications for Hymenoptera venom immunotherapy.
• To assess the efficacy of venom immunotherapy in preventing recurrent anaphylaxis.
• To provide guidance on managing patients with Hymenoptera sting allergies.

Main Methods:

• Review of clinical data on Hymenoptera sting reactions and anaphylaxis.
• Analysis of risk factors for recurrent anaphylaxis.
• Evaluation of immunotherapy outcomes in patient cohorts.

Main Results:

• Patients with a history of anaphylaxis and positive venom skin tests have a high risk (60% adults, 20-32% children) of future reactions.
• Immunotherapy significantly reduces sting-induced reaction incidence to 3% after 4 years.
• Large local reactions, unlike anaphylaxis, do not typically warrant immunotherapy.

Conclusions:

• Hymenoptera venom immunotherapy is indicated for patients with a history of anaphylaxis to Hymenoptera stings.
• Immunotherapy is highly effective in preventing severe recurrent sting reactions.
• Patient education on avoidance and epinephrine use is crucial for all at-risk individuals.